Cabazitaxel-d9 (Synonyms: XRP6258-d9; RPR-116258A-d9; taxoid XRP6258-d9) |
Katalog-Nr.GC45395 |
Cabazitaxel-d9 ist Deuterium mit der Bezeichnung Cabazitaxel. Cabazitaxel ist ein halbsynthetisches Derivat des natÜrlichen Taxoids 10-Deacetylbaccatin III mit potenzieller antineoplastischer AktivitÄt.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1383572-19-7
Sample solution is provided at 25 µL, 10mM.
Cabazitaxel-d9 is intended for use as an internal standard for the quantification of cabazitaxel by GC- or LC-MS. Cabazitaxel is a second generation semisynthetic taxane derived from 10-deacetylbaccatin III .1 It stabilizes microtubule assembly by reducing lag time for tubulin assembly (LT50 = 100 nM) and the rate of cold-induced microtubule depolymerization (IC50s = 100-250 nM) in vitro. Cabazitaxel inhibits proliferation of P388, HL-60, Calc18, and KB cells (IC50s = 4-41 nM), as well as P-glycoprotein-expressing, drug-resistant versions of these cell lines (IC50s = 16-414 nM). In vivo, cabazitaxel dose-dependently reduces tumor growth in docetaxel-susceptible N87 human gastric carcinoma and docetaxel-resistant UISO BCA-1 breast cancer mouse xenograft models. Formulations containing cabazitaxel have been used in combination with prednisone in the treatment of hormone-refractory metastatic prostate cancer.
References
1. Vrignaud, P., SÉmiond, D., Lejeune, P., et al. Preclinical antitumor activity of cabazitaxel, a semisynthetic taxane active in taxane-resistant tumors. Clin. Cancer Res. 19(11), 2973-2983 (2013).
Average Rating: 5
(Based on Reviews and 34 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *